Brief: Invion Achieves Major Milestone Towards Clinical Trials
21/11/2023 08:17
Nov 21 (Reuters) - Invion Ltd IVX.AX :
* ACHIEVES MAJOR MILESTONE TOWARDS CLINICAL TRIALS WITH
SUCCESSFUL
MANUFACTURING OF INV043 UNDER GMP STANDARDS
Source text for Eikon: ID:nASXbWgn32
Further company coverage: IVX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invion
See all newsAustralia's Invion rises after securing clinical trial funding arrangements
Brief: Invion Ltd Says Funding Agreements Cover Up To 85% Of Clinical Trials Costs
Brief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Australia's Invion enters ophthalmology agreement with Sangmyung Innovation
Brief: Invion Signs First Ophthalmology Collaboration Agreement With Sangmyung Innovation